Cargando…
Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies
A monogenic etiology can be identified in up to 40% of people with severe epilepsy. To address earlier and more appropriate treatment strategies, clinicians are required to know the implications that specific genetic causes might have on pathophysiology, natural history, comorbidities, and treatment...
Autores principales: | Guerrini, Renzo, Balestrini, Simona, Wirrell, Elaine C., Walker, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336826/ https://www.ncbi.nlm.nih.gov/pubmed/34493617 http://dx.doi.org/10.1212/WNL.0000000000012744 |
Ejemplares similares
-
Rare and Complex Epilepsies from Childhood to Adulthood: Requirements for Separate Management or Scope for a Lifespan Holistic Approach?
por: Balestrini, Simona, et al.
Publicado: (2021) -
Widespread genomic influences on phenotype in Dravet syndrome, a ‘monogenic’ condition
por: Martins Custodio, Helena, et al.
Publicado: (2023) -
Steps to Improve Precision Medicine in Epilepsy
por: Balestrini, S., et al.
Publicado: (2023) -
A Review of Targeted Therapies for Monogenic Epilepsy Syndromes
por: Zimmern, Vincent, et al.
Publicado: (2022) -
Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies
por: Goodspeed, Kimberly, et al.
Publicado: (2022)